# Anesthetic Considerations in Congenital Myasthenic Syndrome: A Case Report

**Authors:** Ziyad O Knio, Joseph Dean, Joseph O'Brien

PMC · DOI: 10.7759/cureus.99454 · 2025-12-17

## TL;DR

This case report highlights anesthetic challenges in congenital myasthenic syndrome and suggests safe practices for managing these patients during surgery.

## Contribution

The report raises concerns about sensitivity to neuromuscular blocking agents and suggests safety of dilute local anesthetics in this patient group.

## Key findings

- Patients with congenital myasthenic syndrome may show heightened sensitivity to non-depolarizing neuromuscular blocking agents.
- Caudal administration of dilute local anesthetics appears safe for neuraxial analgesia in these patients.

## Abstract

Congenital myasthenic syndrome poses unique anesthetic challenges. Most notably, this rare disease is heterogeneous. Affected individuals’ responses to depolarizing and non-depolarizing neuromuscular blocking agents are poorly understood. Additionally, while neuraxial techniques may confer respiratory benefits due to their opioid-sparing profiles, it is unclear to what extent local anesthetics may impair signal transmission at the neuromuscular junction. This case report raises concern for heightened sensitivity to non-depolarizing neuromuscular blocking agents in patients with congenital myasthenic syndrome. Neuraxial analgesia with caudal administration of dilute local anesthetics appears to be safe.

## Linked entities

- **Diseases:** congenital myasthenic syndrome (MONDO:0018940)

## Full-text entities

- **Diseases:** Congenital Myasthenic Syndrome (MESH:D020294)
- **Chemicals:** neuromuscular (-)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Figures

1 figure with captions in the complete paper: https://tomesphere.com/paper/PMC12810207/full.md

---
Source: https://tomesphere.com/paper/PMC12810207